Once-Weekly Semaglutide in Adults with Overweight or Obesity.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Once-Weekly Semaglutide in Adults with Overweight or Obesity.
- Published In:
- The New England journal of medicine, 384(11), 989-1002 (2021)
- Authors:
- Wilding, John P H(4), Batterham, Rachel L(3), Calanna, Salvatore, Davies, Melanie, Van Gaal, Luc F, Lingvay, Ildiko, McGowan, Barbara M, Rosenstock, Julio, Tran, Marie T D, Wadden, Thomas A, Wharton, Sean, Yokote, Koutaro, Zeuthen, Niels, Kushner, Robert F
- Database ID:
- RPEP-05873
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-05873APA
Wilding, John P H; Batterham, Rachel L; Calanna, Salvatore; Davies, Melanie; Van Gaal, Luc F; Lingvay, Ildiko; McGowan, Barbara M; Rosenstock, Julio; Tran, Marie T D; Wadden, Thomas A; Wharton, Sean; Yokote, Koutaro; Zeuthen, Niels; Kushner, Robert F. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity.. The New England journal of medicine, 384(11), 989-1002. https://doi.org/10.1056/NEJMoa2032183
MLA
Wilding, John P H, et al. "Once-Weekly Semaglutide in Adults with Overweight or Obesity.." The New England journal of medicine, 2021. https://doi.org/10.1056/NEJMoa2032183
RethinkPeptides
RethinkPeptides Research Database. "Once-Weekly Semaglutide in Adults with Overweight or Obesity..." RPEP-05873. Retrieved from https://rethinkpeptides.com/research/wilding-2021-onceweekly-semaglutide-in-adults
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.